Thursday, August 10, 2017 3:35:35 AM
Pharmacyte Biotech's (CIAB) is an unproven encapsulation technology device that has yet to enroll in any US clinical trials therefore allowing it to pass through the latest sanctions placed upon the (DPRK). It has been reported that (CIAB) is regarded as the "miracle technology of the century" among Pharmacyte's internal management and its investors though only a few small studies were done nearly two decades ago. It's been speculated that (CIAB) can protect living cells placed inside the encapsulated cell from outside threats ranging anywhere from cancer to diabetes to now nuclear fallout and warfare.
It's been alleged that Pharmacyte Biotech along with its partner Austrianova is willing to give Mr. Kim Jong un a licensing agreement for the use of (CIAB) in combating and protection from nuclear fallout and warfare.
If joint agreement is reached Mr. Kim Jong un will pay Austrianova (a privately owned company) $1m usd and will receive 35% ownership of the company's restricted stock with options to purchase 500m shares of the company's common stock at a exercise cost of -50% of the value on the signing date with an expiration of five years.
Mr. Kim Jong un will pay Pharmacyte Biotech PMCB; (OTCMKTS) a sum of $25,000 usd in exchange for 25% ownership of the company's restricted stock and 300m shares of the companies common stock with options to purchase 300m shares of common stock at a exercise cost of .03 or closing market value reported by FINRA , whichever is less on the day of signing with an expiration of 5 years.
It's been reported that Mr. Waggoner is very pleased with the pending agreement and looks forward to working with Mr Kim Jong un and his regime. When it was asked why the (DPRK) would be interested in (CIAB)
It's been rumored that Mr. Kim Jong un has resorted to seeking (CIAB) technology in a last ditch effort that it will protect him from the Ass Kicking the U S A is about to bestow upon his ass and his regime."
The agreement is supposed to be reached by the 4th quarter of this year (2017) and if not then 4th quarter of 2018 or 2019,ect...
Further updates pending.
http://austrianova.com/mobile-home-gmp-cell-production-cmo-for-cell-therapy-manufacturing-1-1/index.html
Disclosure: I am involved in and support the SEC whistleblower program, I may be rewarded cash for information that leads to the successful enforcement by the SEC of a federal court or administrative action of 1m+.
Recent PMCB News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 08:40:20 PM
- PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease • Business Wire • 05/21/2024 01:00:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 08:38:38 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/06/2024 02:56:28 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/15/2023 10:25:52 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2023 10:06:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/24/2023 09:00:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:02:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:02:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:01:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:01:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:01:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:00:10 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 11/22/2023 09:00:15 PM
- PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women’s Health Innovator Femasys, Inc. • Business Wire • 11/15/2023 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 10:25:09 PM
- PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology • Business Wire • 10/31/2023 01:15:00 PM
- PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology • Business Wire • 10/31/2023 01:15:00 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 09/21/2023 09:04:07 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/18/2023 10:04:06 AM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 09/15/2023 09:00:03 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 09/12/2023 01:56:25 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 08:05:28 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 08/04/2023 08:40:53 PM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM